Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.

Childhood cancer survivors are at high risk for developing subsequent human papillomavirus (HPV)‐associated cancers. In this issue, Henderson and colleagues examine risk factors for subsequent malignant neoplasms associated with HPV among enrollees in the Childhood Cancer Survivor Study and report that improved, targeted efforts to increase HPV vaccination and HPV‐related surveillance among childhood cancer survivors are needed. [ABSTRACT FROM AUTHOR]